5 pluvicto (lutetium-177)
Ended Awarded
- Contract number
- HT941023F0088
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $162,312
Award facts
- Contract value 100% obligated
- $162,311.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10118, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a BPA call to Advanced Accelerator Applications USA Inc. on May 11, 2023, for PLUVICTO (Lutetium-177) radiopharmaceutical supply with a ceiling value of $162,311.55.
Performance takes place in New York, New York. The call runs through September 15, 2023. PLUVICTO is an FDA-approved lutetium Lu 177 targeted radioligand therapy for prostate cancer treatment delivered on a firm fixed-price basis.
Quick answers
Who was awarded contract HT941023F0088?
HT941023F0088 was awarded to Advanced Accelerator Applications USA Inc. by Defense Health Agency (Department of Defense) on May 11, 2023.
How much is contract HT941023F0088 worth?
The government has obligated $162,312 on HT941023F0088.
Is contract HT941023F0088 an order under another contract?
Yes. HT941023F0088 is a BPA call under HT001419A0001, a blanket purchase agreement.
Was contract HT941023F0088 competed?
The extent of competition for HT941023F0088 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award